Beta-lactamase inhibitors

Details for Australian Patent Application No. 2008321443 (hide)

Owner Protez Pharmaceuticals, Inc.

Inventors Jackson, Randy W.; Burns, Christopher J.

Agent Davies Collison Cave

Pub. Number AU-A-2008321443

PCT Pub. Number WO2009/064413

Priority 61/002,797 13.11.07 US

Filing date 13 November 2008

Wipo publication date 22 May 2009

International Classifications

C07F 5/02 (2006.01) Compounds containing elements of the 3rd Group of the Periodic System

A61K 31/69 (2006.01) - Boron compounds

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064413 Priority application(s): WO2009/064413

7 October 2010 Assignment before Grant

  Protez Pharmaceuticals, Inc. The application has been assigned to Novartis International Pharmaceutical Ltd.

15 September 2011 Assignment before Grant

  Novartis International Pharmaceutical Ltd. The application has been assigned to Novartis AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321444-Beta-lactamase inhibitors

2008321432-Combination EAS and RFID label or tag using a hybrid RFID antenna